Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

2021

Update on Biotron’s HIV-1 and COVID-19 Programs

16 December 2021 by Audrey Thomson

Update on Biotron’s HIV-1 and COVID-19 Programs

Categories 2021, ASX Announcements

Biotron Drug Effective Against COVID-19 in Animals

25 November 2021 by Audrey Thomson

Biotron Drug Effective Against COVID-19 in Animals

Categories 2021, ASX Announcements

Results of Annual General Meeting

23 November 2021 by Audrey Thomson

Results of Annual General Meeting

Categories 2021, ASX Announcements

Presentation to Annual General Meeting

23 November 2021 by Audrey Thomson

Presentation to Annual General Meeting

Categories 2021, ASX Announcements

Commencement of Two Pivotal BIT225 Clinical Trials

1 November 2021 by Audrey Thomson

Commencement of Two Pivotal BIT225 Clinical Trials

Categories 2021, ASX Announcements

Report on Activities for the Quarter ended 30 September 2021

28 October 2021 by Audrey Thomson

Report on Activities for the Quarter Ended 30 September 2021

Categories 2021, ASX Announcements

Quarterly Report 30 September 2021

28 October 202128 October 2021 by Audrey Thomson

Quarterly Report 30 September 2021

Categories 2021, ASX Announcements, Quarterly Reports

Annual Report and Notice of AGM

21 October 202120 October 2021 by Audrey Thomson

Annual Report and Notice of AGM

Categories 2021, ASX Announcements

Year End Accounts and Preliminary Final Report

27 August 2021 by Audrey Thomson

Year End Accounts and Preliminary Final Report

Categories 2021, ASX Announcements

Appendix 4G and Corporate Governance Statement

27 August 2021 by Audrey Thomson

Appendix 4G and Corporate Governance Statement 2021

Categories 2021, ASX Announcements
Older posts
Page1 Page2 Page3 Next →
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 24 April 2025        Legal Notices and Privacy
Cleantalk Pixel